Daily variability of serum prostate-specific antigen in men over 50 years of age

International Urology and Nephrology

Volumn 33, Issue 4, 2001, Pages 641-644

  Tekin, Ali ^a   Atsu, Necmettin ^a   Ozen, Haluk ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Daily variation; Hospitalisation; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CIRCADIAN RHYTHM; CONFIDENCE INTERVAL; DIAGNOSTIC VALUE; HOSPITALIZATION; HUMAN; IMMUNOASSAY; MALE; MEDICAL DECISION MAKING; NORMAL VALUE; PROSTATE CANCER; REFERENCE VALUE; SERUM;

AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; REFERENCE VALUES;

EID: 0035779819     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020583203777     Document Type: Article

References (15)

1. Akimoto S, Masai M, Shimazaki J. Relationship between diurnal rhythm of serum testosterone and two prostatic markers (PSA and PAP) in untreated prostate cancer. Urology 1994; 42: 337.
2. Catalona WJ, Richie JP, deKernion JB et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 1994; 152: 2031.
3. Cooner WH, Mosley BR, Rutherfold CL Jr et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate-specific antigen. J Urol 1990; 143: 1146.
4. Dejter SW Jr., Martin JS, McPherson RA, Lynch JH. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation. Urology 1988; 32: 288.
5. El-Shirbiny AMF, Nilso NT, Pawar HN. Serum prostate-specific antigen: hourly change/24 hours compared with prostatic acid phosphatase. Urology 1990; 35: 88.
6. Komatsu K, Wehner N, Prestigiacomo AF et al. Physiological (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population. Urology 1996; 47: 343.
7. Maatman TJ. The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate. J Urol 1989; 141: 1378-1380.
8. Mannini D, Maver P, Aiello E. et al. Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase activities in patients with prostatic cancer. Urol Res 1988; 16: 9.
9. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907.
10. Ornstein DK, Rao GS, Simith DS et al. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels. J Urol 1997; 157: 195.
11. Riehmann M, Rhodes PR, Cook TD et al. Analysis of variation in prostate-specific antigen values. Urology 1993; 42: 390.
12. Schiffman RB, Ahmann FR, Elvick A. et al. Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared. Clin Chem 1987; 33: 2086.
13. Simak R, Madersbacher S, Zhang ZF, Maier U. The impact of ejaculation on serum prostate specific antigen. J Urol 1993; 150: 895.
14. Stamey TA, Yang N, Hay AR et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909.
15. Winer BJ. Single factor experiments having repeated measures of the same elements. In: Statistical Principles in Experimental Design, 2 ed, 261-308. MacGraw-Hill Book Co, New York 1971.